StockNews.com lowered shares of Welltower (NYSE:WELL – Free Report) from a hold rating to a sell rating in a report issued on Friday morning.
A number of other equities analysts have also recently commented on the company. Mizuho raised their target price on Welltower from $98.00 to $105.00 and gave the stock a buy rating in a report on Wednesday, May 8th. Morgan Stanley raised their target price on Welltower from $103.00 to $107.50 and gave the stock an overweight rating in a report on Thursday, July 11th. Wells Fargo & Company raised their target price on Welltower from $107.00 to $111.00 and gave the stock an overweight rating in a report on Thursday, May 30th. KeyCorp raised their target price on Welltower from $95.00 to $115.00 and gave the stock an overweight rating in a report on Tuesday, July 2nd. Finally, Scotiabank raised their price target on Welltower from $96.00 to $108.00 and gave the company a sector outperform rating in a report on Thursday, May 16th. One analyst has rated the stock with a sell rating, four have given a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the company has an average rating of Moderate Buy and an average target price of $101.32.
View Our Latest Analysis on WELL
Welltower Stock Performance
Welltower (NYSE:WELL – Get Free Report) last released its quarterly earnings results on Monday, April 29th. The real estate investment trust reported $0.22 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.94 by ($0.72). Welltower had a return on equity of 1.77% and a net margin of 6.37%. The firm had revenue of $1.86 billion during the quarter, compared to analysts’ expectations of $1.81 billion. During the same quarter last year, the business earned $0.85 earnings per share. The business’s quarterly revenue was up 19.2% on a year-over-year basis. On average, equities analysts forecast that Welltower will post 4.13 earnings per share for the current year.
Insider Transactions at Welltower
In other news, Director Kenneth J. Bacon sold 1,800 shares of Welltower stock in a transaction dated Tuesday, June 4th. The stock was sold at an average price of $103.91, for a total value of $187,038.00. Following the sale, the director now directly owns 14,579 shares of the company’s stock, valued at $1,514,903.89. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 0.12% of the company’s stock.
Institutional Investors Weigh In On Welltower
Large investors have recently made changes to their positions in the company. Mutual Advisors LLC purchased a new position in Welltower in the fourth quarter worth about $224,000. Raymond James & Associates grew its position in Welltower by 5.8% in the fourth quarter. Raymond James & Associates now owns 333,109 shares of the real estate investment trust’s stock worth $30,036,000 after acquiring an additional 18,351 shares in the last quarter. Pacer Advisors Inc. grew its position in Welltower by 15.5% in the fourth quarter. Pacer Advisors Inc. now owns 36,597 shares of the real estate investment trust’s stock worth $3,300,000 after acquiring an additional 4,901 shares in the last quarter. Assenagon Asset Management S.A. grew its position in Welltower by 3.1% in the fourth quarter. Assenagon Asset Management S.A. now owns 15,539 shares of the real estate investment trust’s stock worth $1,401,000 after acquiring an additional 465 shares in the last quarter. Finally, Schechter Investment Advisors LLC grew its position in Welltower by 8.7% in the fourth quarter. Schechter Investment Advisors LLC now owns 4,237 shares of the real estate investment trust’s stock worth $382,000 after acquiring an additional 339 shares in the last quarter. 94.80% of the stock is owned by institutional investors.
Welltower Company Profile
Welltower Inc (NYSE:WELL), a REIT and S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure. Welltower invests with leading seniors housing operators, post-acute providers and health systems to fund the real estate and infrastructure needed to scale innovative care delivery models and improve people's wellness and overall health care experience.
Featured Stories
- Five stocks we like better than Welltower
- Business Services Stocks Investing
- Is Crypto Cool Again? What Stocks You Should Be Watching
- Using the MarketBeat Stock Split Calculator
- Why Call Options Volume for These 2 Stocks Spiked Together
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- MarketBeat Week in Review – 7/22 – 7/26
Receive News & Ratings for Welltower Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Welltower and related companies with MarketBeat.com's FREE daily email newsletter.